![Amos Eiran](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amos Eiran
Presidente presso Atudot-Executive Search Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Israel Fisher | M | 76 |
Medis El Ltd.
![]() Medis El Ltd. Medical SpecialtiesHealth Technology Part of Medis Technologies Ltd., Medis El Ltd. is a manufacturer of direct liquid fuel cell products for portable electronic devices. The company is based in Lod, Israel. Medis El was acquired by Medis Technologies Ltd. on June 05, 2000. | 32 anni |
Baruch Shapira | M | - |
Atudot-Executive Search Ltd.
![]() Atudot-Executive Search Ltd. Personnel ServicesCommercial Services Atudot-Executive Search Ltd. provides recruitment solutions. The company was founded in 1986 and is headquartered in Tel Aviv, Israel. | 38 anni |
Aimos Eiran | M | 87 |
Medis El Ltd.
![]() Medis El Ltd. Medical SpecialtiesHealth Technology Part of Medis Technologies Ltd., Medis El Ltd. is a manufacturer of direct liquid fuel cell products for portable electronic devices. The company is based in Lod, Israel. Medis El was acquired by Medis Technologies Ltd. on June 05, 2000. | - |
Zeev Nahmoni | M | 83 |
Medis El Ltd.
![]() Medis El Ltd. Medical SpecialtiesHealth Technology Part of Medis Technologies Ltd., Medis El Ltd. is a manufacturer of direct liquid fuel cell products for portable electronic devices. The company is based in Lod, Israel. Medis El was acquired by Medis Technologies Ltd. on June 05, 2000. | - |
Jasmine Wagman-Negev | F | - |
Medis El Ltd.
![]() Medis El Ltd. Medical SpecialtiesHealth Technology Part of Medis Technologies Ltd., Medis El Ltd. is a manufacturer of direct liquid fuel cell products for portable electronic devices. The company is based in Lod, Israel. Medis El was acquired by Medis Technologies Ltd. on June 05, 2000. | 17 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Yuval Cohen | M | 49 |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | 8 anni |
Allan Shaw | M | 59 |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | - |
Robert Francis Doman | M | 74 |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | 2 anni |
Alan G. Harris | M | 72 |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | - |
Gur Roshwalb | M | 55 |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | - |
David Sidransky | M | 64 |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | 3 anni |
Fredric D. Price | M | 78 |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | - |
Pablo Jimenez | M | 59 |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 8 | 61.54% |
Israele | 5 | 38.46% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Amos Eiran
- Contatti personali